A detailed history of Staley Capital Advisers Inc transactions in Pfizer Inc stock. As of the latest transaction made, Staley Capital Advisers Inc holds 2,076,824 shares of PFE stock, worth $55.5 Million. This represents 2.73% of its overall portfolio holdings.

Number of Shares
2,076,824
Previous 2,091,262 0.69%
Holding current value
$55.5 Million
Previous $58.5 Million 2.72%
% of portfolio
2.73%
Previous 2.72%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$27.7 - $31.39 $399,932 - $453,208
-14,438 Reduced 0.69%
2,076,824 $60.1 Million
Q2 2024

Aug 13, 2024

BUY
$25.26 - $29.6 $14.9 Million - $17.5 Million
591,016 Added 39.39%
2,091,262 $58.5 Million
Q1 2024

May 06, 2024

BUY
$25.89 - $29.73 $5.07 Million - $5.82 Million
195,696 Added 15.0%
1,500,246 $41.6 Million
Q4 2023

Feb 12, 2024

SELL
$26.13 - $33.94 $1.09 Million - $1.41 Million
-41,637 Reduced 3.09%
1,304,550 $37.6 Million
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $1.77 Million - $2.07 Million
55,290 Added 4.28%
1,346,187 $44.7 Million
Q2 2023

Aug 15, 2023

BUY
$36.12 - $41.79 $1.81 Million - $2.1 Million
50,173 Added 4.04%
1,290,897 $47.4 Million
Q1 2023

May 10, 2023

BUY
$39.39 - $51.28 $1.99 Million - $2.58 Million
50,407 Added 4.23%
1,240,724 $50.6 Million
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $409,985 - $535,190
-9,820 Reduced 0.82%
1,190,317 $61 Million
Q3 2022

Nov 10, 2022

SELL
$43.76 - $53.42 $699,984 - $854,506
-15,996 Reduced 1.32%
1,200,137 $52.5 Million
Q2 2022

Aug 05, 2022

SELL
$46.53 - $55.17 $158,062 - $187,412
-3,397 Reduced 0.28%
1,216,133 $63.8 Million
Q1 2022

May 12, 2022

BUY
$45.75 - $56.69 $315,720 - $391,217
6,901 Added 0.57%
1,219,530 $63.1 Million
Q4 2021

Feb 08, 2022

SELL
$41.32 - $61.25 $1.57 Million - $2.33 Million
-37,965 Reduced 3.04%
1,212,629 $71.6 Million
Q3 2021

Nov 05, 2021

SELL
$39.25 - $50.42 $295,160 - $379,158
-7,520 Reduced 0.6%
1,250,594 $53.8 Million
Q2 2021

Aug 09, 2021

BUY
$35.91 - $40.68 $1.35 Million - $1.53 Million
37,575 Added 3.08%
1,258,114 $49.3 Million
Q1 2021

May 06, 2021

BUY
$33.49 - $37.77 $2.8 Million - $3.16 Million
83,737 Added 7.37%
1,220,539 $44.2 Million
Q4 2020

Feb 08, 2021

SELL
$33.47 - $42.56 $123,738 - $157,344
-3,697 Reduced 0.32%
1,136,802 $41.8 Million
Q3 2020

Nov 13, 2020

SELL
$31.75 - $37.25 $501,713 - $588,624
-15,802 Reduced 1.37%
1,140,499 $41.9 Million
Q2 2020

Aug 18, 2020

SELL
$30.12 - $36.54 $60,240 - $73,080
-2,000 Reduced 0.17%
1,156,301 $37.8 Million
Q2 2020

Aug 07, 2020

SELL
$30.12 - $36.54 $3.03 Million - $3.68 Million
-100,599 Reduced 7.99%
1,158,301 $37.9 Million
Q1 2020

May 08, 2020

BUY
$27.03 - $38.62 $1.42 Million - $2.03 Million
52,507 Added 4.35%
1,258,900 $41.1 Million
Q4 2019

Feb 04, 2020

BUY
$32.92 - $37.36 $581,498 - $659,927
17,664 Added 1.49%
1,206,393 $47.3 Million
Q3 2019

Nov 08, 2019

BUY
$32.49 - $42.13 $3.09 Million - $4.01 Million
95,155 Added 8.7%
1,188,729 $42.7 Million
Q2 2019

Aug 09, 2019

BUY
$36.98 - $41.52 $747,957 - $839,783
20,226 Added 1.88%
1,093,574 $47.4 Million
Q1 2019

May 10, 2019

BUY
$37.5 - $41.2 $320,325 - $351,930
8,542 Added 0.8%
1,073,348 $45.6 Million
Q4 2018

Feb 05, 2019

SELL
$38.47 - $43.86 $1.85 Million - $2.11 Million
-48,031 Reduced 4.32%
1,064,806 $46.5 Million
Q3 2018

Nov 09, 2018

BUY
$34.47 - $41.81 $122,023 - $148,007
3,540 Added 0.32%
1,112,837 $49 Million
Q2 2018

Aug 08, 2018

SELL
$32.98 - $35.16 $84,758 - $90,361
-2,570 Reduced 0.23%
1,109,297 $40.2 Million
Q1 2018

May 09, 2018

BUY
$31.91 - $37.02 $2.73 Million - $3.17 Million
85,665 Added 8.35%
1,111,867 $39.5 Million
Q4 2017

Feb 12, 2018

BUY
$33.26 - $35.29 $183,927 - $195,153
5,530 Added 0.54%
1,026,202 $37.2 Million
Q3 2017

Nov 09, 2017

BUY
$31.0 - $34.15 $52,793 - $58,157
1,703 Added 0.17%
1,020,672 $36.4 Million
Q2 2017

Aug 14, 2017

BUY
N/A
1,018,969
1,018,969 $34.2 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Staley Capital Advisers Inc Portfolio

Follow Staley Capital Advisers Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Staley Capital Advisers Inc, based on Form 13F filings with the SEC.

News

Stay updated on Staley Capital Advisers Inc with notifications on news.